Related Experiment Videos

Comparative CD43 behavior on monocytes and lymphocytes in kidney transplants

S Jégo1, S Sabri, M Soler

  • 1INSERM U 387, Hôpital de Sainte-Marguerite, Marseille, France.

Nephron
|November 30, 2000
PubMed

Insights

CD43 dys-sialylation, a modification of sialic acid epitopes, is observed in kidney transplant recipients (KTR) monocytes. This alteration, potentially linked to cyclosporin, may affect monocyte function and adhesion.

Area of Science:

  • Immunology
  • Cell Biology
  • Transplantation Science

Background:

  • CD43 exhibits sialylation modifications in cytokine-stimulated human monocytic cells.
  • Monocytes play critical roles in immune responses and post-transplant complications.

Purpose of the Study:

  • To investigate CD43 expression and sialylation status on monocytes from kidney transplant recipients (KTR).
  • To explore the potential role of cyclosporin (CsA) in CD43 dys-sialylation in KTR.

Main Methods:

  • Flow cytometry using monoclonal antibodies targeting sialic acid-dependent (L60) and -independent (L10) CD43 epitopes.
  • Analysis of CD43 expression on monocytes and lymphocytes from KTR and healthy controls.
  • In vitro experiments using THP-1 (monocytic) and Jurkat (lymphoid) cell lines treated with CsA.

Main Results:

  • KTR monocytes showed altered CD43 expression profiles, with decreased L60 staining in 54% and a double population in 20% of patients.
  • Decreased CD43 sialylation (dys-sialylation) was more prevalent in KTR within 3 months post-transplantation.
  • L10 epitope expression remained unaltered, confirming dys-sialylation, and CsA treatment reduced CD43 expression in monocytic cells but not lymphoid cells.

Conclusions:

  • Kidney transplant recipients exhibit CD43 dys-sialylation on monocytes, particularly in the early post-transplant period.
  • Cyclosporin may contribute to this dys-sialylation, potentially impacting monocyte adhesion and function in KTR.

Related Concept Videos